Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Hepatitis B
Related studies linked through entity extraction aliases.
Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans
- Status
- COMPLETED
- Phase
- NA
Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP)
- Status
- COMPLETED
- Phase
- N/A
Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
- Status
- TERMINATED
- Phase
- PHASE2
Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts
- Status
- COMPLETED
- Phase
- PHASE4
Hepatitis B Vaccination in HIV-infected Adults
- Status
- COMPLETED
- Phase
- PHASE4
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.
- Status
- COMPLETED
- Phase
- PHASE3
Chronic Hepatitis B and C Recall Northern Holland
- Status
- UNKNOWN
- Phase
- N/A
First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides
- Status
- UNKNOWN
- Phase
- PHASE4
Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age
- Status
- COMPLETED
- Phase
- NA
Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively
- Status
- WITHDRAWN
- Phase
- NA
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection
- Status
- TERMINATED
- Phase
- PHASE2
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection
- Status
- TERMINATED
- Phase
- PHASE2
Thousand Asian American Study
- Status
- COMPLETED
- Phase
- N/A
A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
- Status
- COMPLETED
- Phase
- PHASE4
Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
- Status
- TERMINATED
- Phase
- PHASE2